The Management of CLL in Elderly Patients
Alessandra Ferrajoli, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the management of chronic lymphocytic leukemia (CLL) in elderly patients.
Alessandra Ferrajoli, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the management of chronic lymphocytic leukemia (CLL) in elderly patients.
Clinical Pearls:
- Clinical trials that have shown that the management of elderly patients with CLL needs to be different from the fit and young population
- Although there is no standard of care for elderly patients with CLL, physicians are starting to move away from chemoimmunotherapy and moving towards monoclonal antibody-based treatment
- In addition to considering the fitness and type of disease of elderly patients, physicians must consider transportation difficulties, limited financial budgets and ease of treatment
Socioeconomic Factors Impact Access to Allogeneic Stem Cell Transplant in AML
December 11th 2024Socioeconomic factors significantly impact access to allogeneic hematopoietic stem cell transplant in patients with acute myeloid leukemia, with certain groups less likely to receive this potentially lifesaving treatment.
Read More
Novel BTK Degrader BGB-16673 Shows Activity in WM and CLL/SLL
December 10th 2024The novel Bruton tyrosine kinase degrader BGB-16673 shows promise in relapsed/refractory Waldenström macroglobulinemia previously exposed to BTK inhibitors, and in heavily pretreated patients with R/R chronic lymphocytic leukemia/small lymphocytic lymphoma.
Read More
